Megan Clancy is an Infectious Disease physician affiliated with Providence Alaska Medical Center. OpenAlex indexes 11 publications with 337 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3500 Latouche Street
Suite 200
Anchorage, AK 995084248
Telephone
907-561-4362Registry record last updated 28 Feb 2024.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20241 payment
- Ferring Pharmaceuticals Inc.Program year20241 payment
- Insmed, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
69.5%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor11%Descovy41%Abacavir25%Triumeq19%Emtricitabine-Tenofovir Disop16%Part D<11 patientsTetracycline-class Drug10.2%Doxycycline Monohydrate75%Doxycycline Hyclate25%Part D<11 patients+ 13 more classes in this area
Nervous system
10.9%gamma-Aminobutyric Acid A Receptor Positive Modulator6%Zolpidem Tartrate100%Part D<11 patientsSSRI3%Escitalopram Oxalate100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
9.1%Proton pump inhibitor9.1%Pantoprazole Sodium51%Omeprazole49%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug‐Resistant <i>Pseudomonas aeruginosa</i> : A Case Report
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
2019 - Alemtuzumab Associated Listeria Monocytogenes Meningitis
Journal of Contemporary Pharmacy Practice
2019 - Disseminated cryptococcosis associated with administration of eculizumab
American Journal of Health-System Pharmacy
2018 - Fatal Outbreak of an Emerging Clone of Extensively Drug-Resistant<i>Acinetobacter baumannii</i>With Enhanced Virulence
Clinical Infectious Diseases
2015 - Outcomes of Cognitive-Behavioral Treatment for Insomnia on Insomnia, Depression, and Fatigue for Individuals with Multiple Sclerosis
International Journal of MS Care
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Jeremy Gitomer, MD
Providence Alaska Medical Center
Sherrie Richey, MD
Providence Alaska Medical Center
Dion Roberts, MD
Providence Alaska Medical Center
Jered Weinstock, MD
Providence Alaska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”